|Videos|November 8, 2022
The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate Video
Author(s)Nanoform
Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.
Related Content
Trending on Pharmaceutical Technology
1
Using Automation to Enhance Pharmaceutical Manufacturing
2
FDA Activity Round Up – July 2026
3
Hidden Cost Drivers in Oligonucleotide Manufacturing
4
Mid-Year Check-In: Are Henrik Johanning's Pharma Manufacturing Predictions Holding Up?
5